In Korea, all medical institutions claim insurance reimbursements for services to the Health Insurance Review and Assessment Service (HIRA). Thus, HIRA databases reflect the general medical services provided in Korea. Since the entire HIRA database is too big to analyze, HIRA provides a specific set of data according to researcher's requests. HIRA also provides some relatively small sized data sets (statistically extracted, anonymized, and annualized) for research and public purposes \[[@b1-jptm-2016-03-04]\]. These sample data included national patient sample (NPS), a national inpatient sample, an adult patient sample (65 years or older), and a pediatric patient sample. To the best of our knowledge, this is the first pathology-related analysis using HIRA data.

We conducted two pathology-related studies using HIRA-NPS data. First, we analyzed the rate of surgical pathologic examinations in Korea. After Kamegoro Inamoto introduced pathology to Korea in 1914, pathologic examinations have played a major role in medical services for the improvement of overall care \[[@b2-jptm-2016-03-04]\]. However, research on the frequency of pathologic examinations in this nation as a whole have not been performed due to a restriction on the sharing of personal medical records.

Next, we analyzed the pathologic results of endoscopic submucosal dissection (ESD) specimens. ESD is considered as an initial treatment modality for early and localized gastric carcinoma or benign epithelial neoplasm \[[@b3-jptm-2016-03-04]\]. We evaluated several ESD-related parameters. After ESD and pathologic examination, surgical treatment is called for in those cases that show tumor cells in the resection margins, endolymphatic tumor emboli, or submucosal invasion \[[@b4-jptm-2016-03-04]\]. Several papers have been published on this subject, but most of them are from a single institute and so do not incorporate the data of those patients who later went on to undergo additional surgery in different hospitals \[[@b5-jptm-2016-03-04],[@b6-jptm-2016-03-04]\]. One of the advantageous features of the HIRA database is that patients can be tracked through several medical institutions, thereby enabling the study of a more complete data set including those that received secondary treatment in one hospital after ESD in another hospital.

MATERIALS AND METHODS
=====================

The sample data used in this study was HIRA-NPS-2013-0094. This sample was composed of 26 text files, and the total file size was 16.6 gigabytes (GB). The HIRA data tables were composed of five main tables (general specification, healthcare services, diagnosis information, prescriptions, and general information about the medical institutions). Each table was conjoined with proper claim numbers or medical institution numbers. The disease codes were based on the Korean Standard Classification of Disease (KCD). Specifications of the computer that was used to analyze the data were as follows: central processing unit (CPU), i3-2120 3.30 GHz (Intel, Santa Clara, CA, USA); 32 GB main memory; operating system (OS), Ubuntu 14.04.3 long-term support (LTS); and R 3.2.2 analysis software. The pathologic examination codes used in this study are summarized in [Table 1](#t1-jptm-2016-03-04){ref-type="table"}. The sample data contained 22,344,536 claims in 1,361,717 patients (selection probability, 0.03; sampling weight, 33.3).

RESULTS
=======

Pathologic examination statistics in Korea
------------------------------------------

In the year 2013, 163,372 pathologic examinations were performed in 103,528 patients (45,897 men and 57,631 women). The mean and median ages of the patients were 51.8 and 53 years, respectively. The skewness and kurtosis of patient age were --0.251 and 2.775, respectively. The pathologic examination data and medical institutions according to administrative district are summarized in [Table 2](#t2-jptm-2016-03-04){ref-type="table"}. The total numbers of medical institutions according to administrative district are summarized in [Appendix 1](#app1-jptm-2016-03-04){ref-type="app"}. In total, 43.5% of the tertiary hospitals (10/23), 15.6% of the general hospitals (48/307), and 23.8% of the other institutions (12,090/50,868) were located in Seoul. In addition, 32.9% of the surgical pathologic examinations (53,711/163,372) were requested in medical institutions located in Seoul.

Almost all medical and dental departments requested pathologic examinations ([Table 3](#t3-jptm-2016-03-04){ref-type="table"}). Internal medicine (74,232, 45.4%), general surgery (34,808, 21.3%), obstetrics and gynecology (19,382, 11.9%), and urology (9,951, 6.1%) were the most common medical departments (84.7%) requesting pathology examinations. A small subset (38/17,892, 0.2%) of immunohistochemical (IHC) stains were not interpreted by qualified doctors (not claimed as "C5575006") (data not shown). Claims for acetylcholinesterase (C5564) and chloroacetate esterase (C5565) examinations were not found in our data.

Among pathologic examination-associated claims, 162,002 examinations (99.2%) had proper claim codes (examination codes 09 and sub-code 01 (performed in their own institutions) or 02 (performed in outside institutions). Among pathologic examinations, 65.8% were performed in tertiary or general hospitals (39,385 and 67,225 cases, respectively) ([Table 4](#t4-jptm-2016-03-04){ref-type="table"}). Almost all examinations claimed by tertiary hospitals were performed in their institute (39,349/39,385, 99.9%), and 85% of examinations claimed by general hospitals were performed (57,163/67,225) in their institute. The other medical institutions claimed considerable pathologic examinations performed by outside services (52,214/55,392, 94.3%).

According to the claims, 76,016 pathologic examinations (44.7%) were performed due to malignancy (disease code "C") or non-malignant tumorous conditions (disease code "D00-D48") ([Table 5](#t5-jptm-2016-03-04){ref-type="table"}). IHC stains were more frequently performed in tumorous conditions (15,336/17,892, 85.7%). Pathologic examination of biopsy specimens was performed more frequently in non-tumorous conditions (42,661/61,875, 68.9%).

ESD-related statistics
----------------------

In total, 509 ESDs were performed in 490 patients (341 males and 149 females) in 109 medical institutions. The median age of the patients was 66 years (age, 29 to 89 years; 1st quantile, 58 years; 3rd quantile, 71.75 years). The majority of patients (n=472) underwent one ESD; 17 patients underwent two ESDs (10 patients underwent simultaneous ESD, while seven patients underwent ESDs at different times), and one patient underwent three ESDs (two ESDs at the same time).

The disease codes noted when patients underwent ESD were as follows: C16 (malignant neoplasm of stomach), 213 patients (43.5%); non-C16, 277 patients (56.5%); D00.2 (carcinoma *in situ* of stomach), 17 patients; D13.1 (benign neoplasm of stomach), 226 patients; D13.9 (benign neoplasm of ill-defined site within the digestive system), one patient; and other, 33 patients. Disease codes changed after the ESD in 10.5% of the non-C16 patients (29/277): D00.2 to C16, seven patients; D13.1 to D00.2, three patients; D13.1 to C16, 18 patients; and D13.9 to C16, one patient ([Table 6](#t6-jptm-2016-03-04){ref-type="table"}).

Twenty-one patients (21/490, 4.3%) underwent gastrectomy following ESD, and all of these patients underwent ESD for only once. Fifteen patients received surgery at the same medical institution where ESD was performed, and six patients received surgery at different medical institutions. The mean time between ESD and surgery was 44 days. Two patients changed diagnosis (benign to malignant) after ESD. One patient underwent ESD and surgery during the same hospitalization period.

For further analysis, 472 patients who underwent ESD for only once were selected ([Table 7](#t7-jptm-2016-03-04){ref-type="table"}) (C16, 202 patients; D00.2, 17 patients; D13.1, 220 patients; D13.9, one patient; other, 32 patients). In total, 70.0% of these pathologic examinations (329/472) were requested for histologic mapping (C5508). IHC studies were performed in 22.5% of ESDs (106/472). Approximately one-third of the gastric cancer specimens (66/202, 32.7%) and 15.0% of the gastric benign neoplasm specimens (33/220) were subject to IHC studies.

DISCUSSION
==========

In this study, we examined nation-wide statistics regarding surgical pathologic examination. Considering sampling weight, we estimate that 5,440,288 (163,372×33.3) pathologic examinations were performed in Korea in 2013. We also surveyed pathologic examinations according to administrative district, requesting department, type of medical institutions, and patient conditions. These data will be useful for future planning and allocation of resources in the field of pathology and for the Korean Society of Pathologists.

There have been several reports regarding diagnostic discrepancies between endoscopic forceps biopsy and ESD, as well as between ESD and surgery. Recently, two large, single-center, retrospective studies revealed that 22.8% (465/2,041) and 31.7% (587/1,850) of cases changed diagnosis after endoscopic resection in Asan Medical Center (Seoul, Korea) and Samsung Medical Center (Seoul, Korea), respectively \[[@b5-jptm-2016-03-04],[@b6-jptm-2016-03-04]\]. Our HIRA-NPS data revealed that only 10.9% of nation-wide cases experienced a change of diagnosis after ESD. HIRA-NPS data does not include detailed pathologic diagnosis information such as tumor size, tumor differentiations, dysplastic degrees, etc., so further analysis for clarifying such differences was limited. Shin *et al.* \[[@b7-jptm-2016-03-04]\] reported that complete resection rates were not different according to absolute or expanded ESD indications, though their data were not HIRA data. Although HIRA-NPS data was not available for a sufficient number of ESD patients (509 ESDs in 490 patients) to allow for an accurate assessment, and only limited clinicopathological information was available, the problems associated with the relatively few number of patients can be overcome through further research using the raw HIRA data.

Histologic mapping of ESD specimens is recommended by The Gastrointestinal Pathology Study Group of the Korean Society of Pathologists \[[@b8-jptm-2016-03-04]\]. However, 30.2% (143/472) of ESD specimens were not claimed as "C5508" (histologic mapping without lymph node dissection). Because precise histologic diagnosis of the ESD specimen is essential to treat patients, we suggest that nationwide surveys be conducted in order to assure quality of pathologic examination of ESD specimens. IHC staining was performed in 22.5% (106/472) of ESD cases. Unlike tissue immunofluorescent microscopic examinations or enzyme histochemistries, HIRA data does not list the specific antibodies used for IHC stains. Thus, further analysis of IHC studies using HIRA data was limited.

The main limitations of our analysis are statistical issues based on probability sampling. Our estimates were calculated from statistically extracted data from one year. Further analysis using HIRA raw data will be needed to decrease the statistical errors and bias and to evaluate changes over time. During our analysis, we experienced many challenges; therefore, we provide advice and guidance for other researchers who would like to analyze the HIRA database.

\(1\) It is essential to understand the framework of the HIRA database \[[@b9-jptm-2016-03-04]\]. The HIRA data is intended for insurance claims and not for research. Detailed clinicopathological data are not provided. (2) Sample data are not appropriate for analyses requiring long-term follow-up. (3) Some claim codes have sub-codes (in most cases, additional charges by experts). (4) Disease codes and claims are not always accurate. (5) The analysis system should have at least 32 GB of main memory. (6) It is helpful to create relatively small data tables to decrease operation time. In the usual setting, R should use only one CPU core during calculation.
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Numbers of medical institutions according to administrative districts


###### 

Pathologic examination claim codes using in this study

  Histologic examination                                                                                                       Code
  ---------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------
  Biopsy: 1--3 pieces/4--6 pieces/7--9 pieces/10--12 pieces/more than 13 pieces                                                C5911/C5912/C5913/C5914/C5915
  Resected specimen requiring gross sectioning (non-malignant): paraffin blocks ≤ 6/paraffin blocks ≥ 7                        C5916/C5917
  Resected specimen for malignant tumor requiring gross sectioning                                                             
   With lymph node dissection: paraffin blocks ≤ 20/paraffin blocks ≥ 21                                                       C5918/C5919
   Without lymph node dissection: paraffin blocks ≤ 15/paraffin blocks ≥ 16                                                    C5500/C5504
  Histologic mapping of tumor: with lymph node dissection/without lymph node dissection                                        C5505/C5508
  Emergency histopathologic examination during surgery (frozen section): 1--2 specimens/3--6 specimens/more than 7 specimens   C5511/C5512/C5513
  Tissue immunofluorescent microscopic examination: IgG/IgA/IgM/IgE/C3/C4/HbsAg/fibrinogen/others                              C5541/C5542/C5543/C5544/C5545/C5549/C5546/C5547/C5548
  Tissue electron microscopy                                                                                                   C5550
  Enzyme histochemistry: ATPase-pH 9.4/ATPase-pH 4.9/NADH/acetylcholinesterase/chloroacetate esterase/others                   C5561/C5562/C5563/C5564/C5565/C5566
  Immunohisto(cyto)chemistry                                                                                                   C5575/C5575006
  Cervicovaginal smear/Liquid-based cervicovaginal cytology                                                                    C5920/CX541
  Body fluid: general/cytospin/cell block after cytopathologic examination/liquid-based body fluid cytopathology               C5930/C5931/C5940/CZ521
  Aspiration/Aspiration and cell block                                                                                         C5941/C5942
  Liquid-based aspiration cytopathology/Liquid-based aspiration cytopathology and Cell block                                   C5943/C5944
  Flurescence *in situ* hybridization: *HER2* gene                                                                             C5967/C5967006
  Silver *in situ* hybridization: *HER2* gene                                                                                  CZ968/CZ968006

HBsAg, hepatitis B surface antigen.

###### 

Pathologic examinations claims and requesting medical institutions according to administrative districts (sort based on the total number of claims)

  Administrative district   Tertiary hospital   General hospital   Other institutions   Total     Total estimates
  ------------------------- ------------------- ------------------ -------------------- --------- -----------------
  Seoul                     25,547              16,164             12,000               53,711    1,788,576
  Gyeonggi-do               1,632               16,203             10,905               28,740    957,042
  Busan                     3,276               4,877              5,135                13,288    442,490
  Daegu                     1,164               5,933              5,185                12,282    408,991
  Incheon                   2,545               2,377              2,465                7,387     245,987
  Gyeongsangnam-do          760                 3,561              3,053                7,374     245,554
  Gwangju                   1,211               2,438              1,910                5,559     185,115
  Daejeon                   970                 2,300              1,781                5,051     168,198
  Jeollabuk-do              857                 1,935              2,162                4,954     164,968
  Gyeongsangbuk-do          \-                  2,252              2,638                4,890     162,837
  Jeollanam-do              \-                  2,655              1,621                4,276     142,391
  Chungcheongnam-do         \-                  2,024              1,861                3,885     129,371
  Gangwon-do                850                 1,791              1,046                3,687     122,777
  Chungcheongbuk-do         573                 1,178              1,611                3,362     111,955
  Ulsan                     \-                  1,561              1,799                3,360     111,888
  Jeju                      \-                  1,135              380                  1,515     50,450
  Sejong-si                 \-                  \-                 51                   51        1,698
  Total                     39,385              68,384             55,603               163,372   5,440,288

###### 

Pathologic examinations requests statuses according to medical departments (sort based on the total number of claims)

  Department code                           Biopsy   Resection, non- malignant   Resection, malignant (LN/non-LN)   Histologic mapping (LN/non-LN)   Frozen sections   IF      EM    Enzyme   IHC      Uterine cervical examinations (smear/liquid)   Body fluid (conventional/liquid)   Aspiration (conventional/liquid)   HER2 (FISH/SISH)   Total     Total estimates
  ----------------------------------------- -------- --------------------------- ---------------------------------- -------------------------------- ----------------- ------- ----- -------- -------- ---------------------------------------------- ---------------------------------- ---------------------------------- ------------------ --------- -----------------
  Internal medicine                         40,683   12,463                      120 (62/58)                        636 (2/634)                      85                1,329   184   12       5,248    189 (89/100)                                   8,219 (5,531/2,688)                5,053 (4,752/301)                  11 (6/5)           74,232    2,471,926
  General surgery                           8,066    9,614                       2,893 (2,466/427)                  335 (292/43)                     1,870             178     31    0        7,495    49 (18/31)                                     722 (519/203)                      3,533 (3,457/76)                   22 (3/19)          34,808    1,159,106
  Obstetrics and gynecology                 5,042    6,090                       263 (172/91)                       27 (10/17)                       236               0       1     0        754      6,413 (1,090/5,323)                            351 (198/153)                      205 (196/9)                        0 (0/0)            19,382    645,421
  Urology                                   1,586    1,245                       337 (86/251)                       112 (52/60)                      148               8       4     0        1,176    108 (26/82)                                    5,056 (3,030/2,026)                171 (167/4)                        0 (0/0)            9,951     331,368
  Otorhinolaryngology                       721      2,283                       333 (229/104)                      1 (1/0)                          299               0       4     0        686      1 (0/1)                                        61 (39/22)                         709 (667/42)                       0 (0/0)            5,098     169,763
  Dermatology                               2,156    1,270                       21 (1/20)                          2 (0/2)                          28                203     0     2        436      3(1/2)                                         20 (20/0)                          21 (20/1)                          0 (0/0)            4,162     138,595
  Orthopedic surgery                        750      2,672                       44 (5/39)                          1 (0/1)                          77                5       1     0        193      24 (11/13)                                     261 (226/35)                       63 (61/2)                          0 (0/0)            4,091     136,230
  Neurosurgery                              330      1,062                       75 (1/74)                          0 (0/0)                          183               0       16    0        645      9 (3/6)                                        207 (124/83)                       27 (25/2)                          0 (0/0)            2,554     85,048
  Thoracic surgery                          161      589                         251 (199/52)                       14 (13/1)                        277               0       1     0        502      1 (1/0)                                        324 (233/91)                       35 (26/9)                          0 (0/0)            2,155     71,762
  Family medicine                           905      307                         0 (0/0)                            0 (0/0)                          0                 0       0     0        23       16(5/11)                                       106 (91/15)                        110(109/1)                         0 (0/0)            1,467     48,851
  Radiology                                 541      49                          0 (0/0)                            0 (0/0)                          0                 0       0     0        207      5 (3/2)                                        17(15/2)                           306 (260/46)                       0 (0/0)            1,125     37,463
  Plastic surgery                           50       680                         46 (6/40)                          9 (7/2)                          84                0       0     0        117      0 (0/0)                                        3(2/1)                             3(2/1)                             0 (0/0)            992       33,034
  Pediatrics                                227      56                          0 (0/0)                            0 (0/0)                          2                 132     24    5        193      0 (0/0)                                        245 (132/113)                      4 (4/0)                            0 (0/0)            888       29,570
  Neurology                                 171      58                          1 (0/1)                            0 (0/0)                          5                 11      7     18       40       11 (7/4)                                       337 (225/112)                      23 (23/0)                          0 (0/0)            682       22,711
  Dental department                         123      333                         8 (4/4)                            0 (0/0)                          15                17      0     0        27       0 (0/0)                                        17(15/2)                           2 (2/0)                            0 (0/0)            542       18,049
  Emergency medicine                        74       42                          1 (0/1)                            0 (0/0)                          1                 13      3     0        20       9(1/8)                                         203 (160/43)                       5(4/1)                             0 (0/0)            371       12,354
  Ophthalmology                             140      123                         5(1/4)                             0 (0/0)                          10                0       0     0        51       0 (0/0)                                        10(6/4)                            8 (8/0)                            0 (0/0)            347       11,555
  Rehabilitation medicine                   51       17                          0 (0/0)                            0 (0/0)                          1                 12      2     3        5        7(2/5)                                         46 (38/8)                          2 (2/0)                            0 (0/0)            146       4,862
  Laboratory medicine                       5        \-                          0 (0/0)                            0 (0/0)                          0                 0       0     0        71       1 (0/1)                                        0 (0/0)                            0 (0/0)                            0 (0/0)            77        2,564
  Psychiatry                                43       13                          0 (0/0)                            0 (0/0)                          0                 0       0     0        1        3(2/1)                                         15(10/5)                           2 (2/0)                            0 (0/0)            77        2,564
  Pathology                                 2        \-                          0 (0/0)                            0 (0/0)                          0                 0       0     0        0        0 (0/0)                                        5 (5/0)                            45 (45/0)                          0 (0/0)            52        1,732
  General (NOS)                             12       16                          0 (0/0)                            0 (0/0)                          0                 0       0     0        0        1 (0/1)                                        6 (6/0)                            10(10/0)                           0 (0/0)            45        1,499
  Radiation oncology                        16       \-                          0 (0/0)                            0 (0/0)                          0                 0       0     0        0        20 (0/20)                                      1 (0/1)                            6 (6/0)                            0 (0/0)            43        1,432
  Preventive medicine                       4        25                          0 (0/0)                            0 (0/0)                          0                 0       0     0        0        0 (0/0)                                        0 (0/0)                            0 (0/0)                            0 (0/0)            29        966
  Nuclear medicine                          \-       \-                          0 (0/0)                            0 (0/0)                          0                 0       0     0        0        0 (0/0)                                        0 (0/0)                            26 (24/2)                          0 (0/0)            26        866
  Anesthesiology                            6        8                           1 (1/0)                            0 (0/0)                          1                 0       0     0        1        0 (0/0)                                        1 (1/0)                            0 (0/0)                            0 (0/0)            18        599
  Occupational and environmental medicine   9        \-                          0 (0/0)                            0 (0/0)                          0                 0       0     0        1        0 (0/0)                                        1 (1/0)                            0 (0/0)                            0 (0/0)            11        366
  Tuberculosis                              1        \-                          0 (0/0)                            0 (0/0)                          0                 0       0     0        0        0 (0/0)                                        0 (0/0)                            0 (0/0)                            0 (0/0)            1         33
  Total                                     61,875   39,015                      4,399 (3,233/1,166)                1,137 (377/760)                  3,322             1,908   278   40       17,892   6,870 (1,259/5,611)                            16,234 (10,627/5,607)              10,369 (9,872/497)                 33 (9/24)          163,372   5,440,288

LN, with lymph node dissection; non-LN, without lymph node dissection; IF, immunofluorescent; EM, electron microscopy; IHC, immunohisto(cyto)chemistry; FISH, flurescence *in situ* hybridization; SISH, silver *in situ* hybridization; NOS, not otherwise specified.

###### 

Pathologic examination performing places according to medical institutions

  Institution        Tertiary hospital   General hospital   Other medical institutions   Total
  ------------------ ------------------- ------------------ ---------------------------- ---------------
  In own hospital    39,349 (99.9)       57,163 (85.0)      3,178 (5.7)                  99,690 (61.5)
  Outside services   36 (0.1)            10,062 (15.0)      52,214 (94.3)                62,312 (38.5)
  Total              39,385 (100)        67,225 (100)       55,392 (100)                 162,002 (100)

Values are presented as number (%).

###### 

Disease codes of patients at time of pathologic examinations requests

                                                 Tumorous condition    Non-tumorous condition   Total
  ---------------------------------------------- --------------------- ------------------------ -----------------------
  Biopsy                                         19,214                42,661                   61,875
  Resection, non-malignant                       14,900                24,115                   39,015
  Resection, malignant (LN/non-LN)               4,333 (3,203/1,130)   66 (30/36)               4,399 (3,233/1,166)
  Histologic mapping (LN/non-LN)                 1,045 (377/668)       92 (0/92)                1,137 (377/760)
  Frozen sections                                3,041                 281                      3,322
  IF                                             213                   1,695                    1,908
  EM                                             51                    227                      278
  Enzyme                                         0                     40                       40
  IHC                                            15,336                2,556                    17,892
  Uterine cervical examinations (smear/liquid)   3,199 (554/2,645)     3,671 (705/2,966)        6,870 (1,259/5,611)
  Body fluid (conventional/liquid)               7,137 (4,118/3,019)   9,097 (6,509/2,588)      16,234 (10,627/5,607)
  Aspiration (conventional/liquid)               4,514 (4,234/280)     5,855 (5,638/217)        10,369 (9,872/497)
  HER2 (FISH/SISH)                               33 (9/24)             0 (0/0)                  33 (9/24)
  Total                                          73,016                90,356                   163,372

LN, with lymph node dissection; non-LN, without lymph node dissection; IF, immunofluorescent; EM, electron microscopy; IHC, immunohisto(cyto)chemistry; FISH, flurescence *in situ* hybridization; SISH, silver *in situ* hybridization.

###### 

Changes of disease codes after endoscopic submucosal dissections

  Disease code at ESD   Disease code after ESD        
  --------------------- ------------------------ ---- ----
  D00.2                 10                       7    \-
  D13.1                 205                      18   3
  D13.9                 0                        1    0
  Others                33                       0    0
  Total                 248                      26   3

ESD, endoscopic submucosal dissections.

###### 

Pathologic examination codes and number of immunohistochemical stains according to diseases codes at endoscopic submucosal dissections

                                      C16   D00.2   D13.1   D13.9   Others   Total
  ----------------------------------- ----- ------- ------- ------- -------- -------
  Pathologic examination codes                                               
   C5500                              6     0       5       0       0        11
   C5508                              158   3       139     1       28       329
   C5916                              16    3       51      0       2        72
   C5917                              22    11      25      0       2        60
   Total                              202   17      220     1       32       472
  No. of immunohistochemical stains                                          
   0                                  136   14      187     1       28       366
   1                                  42    1       25      0       1        69
   2                                  12    0       5       0       2        19
   3                                  2     1       3       0       1        7
   4                                  2     1       0       0       0        3
   5                                  3     0       0       0       0        3
   6                                  5     0       0       0       0        5
   Total                              202   17      220     1       32       472
